Nanomerics
Phase 3Developing targeted therapies that address serious medical need using proprietary platform technologies for pharmaceutical APIs and genetic therapies.
Founded
2010
Focus
Drug DeliveryNanotechnology
About
Developing targeted therapies that address serious medical need using proprietary platform technologies for pharmaceutical APIs and genetic therapies.
Funding History
2Total raised: $13.5M
Series A$12MMercia Asset ManagementNov 15, 2020
Grant$1.5MInnovate UKJun 15, 2018
Company Info
TypePrivate
Founded2010
LocationLondon, United Kingdom
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile